SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

RPG Life Sciences - Quaterly Results

25 Jul 2025 Evaluate
With no major difference for the quarter endedJune 2025 , the total revenue stood at Rs. 1689.20  millions.The Net proft of the company remain more or less same to Rs. 262.90  millions from Rs. 267.60 millions ,decline by -1.76%.A decline of 407.00 millions was observed in the OP in the quarter ended June 2025 from 414.40 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1689.20 1654.20 2.12 1689.20 1654.20 2.12 6534.30 5820.50 12.26
Other Income 52.30 23.70 120.68 52.30 23.70 120.68 126.80 72.10 75.87
PBIDT 407.00 414.40 -1.79 407.00 414.40 -1.79 1723.30 1353.60 27.31
Interest 1.30 1.50 -13.33 1.30 1.50 -13.33 6.20 4.50 37.78
PBDT 405.70 412.90 -1.74 405.70 412.90 -1.74 2543.10 1349.10 88.50
Depreciation 51.40 52.90 -2.84 51.40 52.90 -2.84 214.30 170.70 25.54
PBT 354.30 360.00 -1.58 354.30 360.00 -1.58 2328.80 1178.40 97.62
TAX 91.40 92.40 -1.08 91.40 92.40 -1.08 496.40 301.80 64.48
Deferred Tax 0.70 -2.70 -125.93 0.70 -2.70 -125.93 -0.50 -23.60 -97.88
PAT 262.90 267.60 -1.76 262.90 267.60 -1.76 1832.40 876.60 109.03
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 24.09 25.05 -3.82 24.09 25.05 -3.82 26.37 23.26 13.40

RPG Life Sciences Share Price

1893.15 14.10 (0.75%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×